05:20 , Jun 16, 2017 |  BC Week In Review  |  Financial News

Ocugen raises $7.5M in series B

Ophthalmology company Ocugen Inc. (Malvern, Pa.) raised $7.5 million in a series B round led by Abdi Ibrahim and JSC Lancaster Group on June 15. Existing individual investors also participated. Ocugen Inc. , Malvern, Pa. ...
01:00 , Feb 17, 2017 |  BC Innovations  |  Targets & Mechanisms

Gilding the Goldfinch

In launching Goldfinch Biopharma Inc. , Third Rock is extending its already heavy footprint in precision medicine into chronic kidney disease. The VC thinks the unfolding genetics in that field can yield disease-modifying therapies and...
08:00 , Nov 12, 2012 |  BC Week In Review  |  Company News

Abdi Ibrahim, Otsuka Pharmaceutical deal

Otsuka and Turkish pharma Abdi Ibrahim established Abdi Ibrahim Otsuka Pharmaceutical A/S, a 50/50 JV to commercialize Otsuka's products in Turkey, including Pletal cilostazol and Samsca . Otsuka said Abdi Ibrahim has exclusive, Turkish rights...
08:00 , Feb 5, 1996 |  BC Week In Review  |  Company News

Scotia Pharmaceuticals plc, Abdi Ibrahim, Handok Pharmaceuticals deal

Abdi and Handok will exclusively distribute SOH's Epogam in Turkey and South Korea, respectively. Epogam, an oral treatment for atopic eczema, works by restoring missing GLA metabolites. Scotia Pharmaceuticals plc (London: SOH), Guildford, U.K.  ...